Viscoelastic solution
US5013714A · kind A · utility
27Cited by
3References
4Claims
0Family size
Inventors
Key dates
| Filing date | Dec 15, 1988 |
| Grant date | May 7, 1991 |
| Priority date | — |
| Expiry date | Dec 15, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/1808
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Viscoelastic solution including a buffered solution, 0.01-8% chondroitin sulfate, 0.1-8% hydroxypropyl methylcellulose, pH adjusted to 6.0-8.0 at a osmolality between 200-400 mOsmol/L. The buffered solution can be HEPES buffered minimum essential media (MEM), phosphate buffer saline (PBS), buffered balanced salt solution, or TC199. A cell growth factor or cell growth supplement is included in the solution.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.